We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

12 hedge funds and large institutions have $76.6M invested in Vaxxinity, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less capital invested

Capital invested by funds: $102M → $76.6M (-$24.9M)

29% less funds holding

Funds holding: 17 → 12 (-5)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
1
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$86.5K
2
Citadel Advisors
Citadel Advisors
Florida
+$59.5K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$685K
2
Millennium Management
Millennium Management
New York
-$489K
3
HF
HRT Financial
New York
-$187K
4
DFCM
Dark Forest Capital Management
Puerto Rico
-$101K
5
CCM
CAAS Capital Management
New York
-$94K
Name Holding Trade Value Shares
Change 		Change in
Stake
PML
1
Prime Movers Lab
Wyoming
$69.8M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$4.31M – – –
SM
3
Scoggin Management
New York
$1.21M – – –
Goldman Sachs
4
Goldman Sachs
New York
$417K -$685K -124,031 -56%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$292K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$237K -$26.9K -4,879 -8%
EMG
7
ETF Managers Group
New Jersey
$167K -$237 -43 -0.1%
HF
8
HRT Financial
New York
$73K -$187K -33,924 -66%
Bank of America
9
Bank of America
North Carolina
$68K +$86.5K +15,658 +7,829%
Citadel Advisors
10
Citadel Advisors
Florida
$46K +$59.5K +10,766 New
Morgan Stanley
11
Morgan Stanley
New York
$34K -$18.7K -3,385 -30%
Millennium Management
12
Millennium Management
New York
– -$489K -87,083 Closed
DFCM
13
Dark Forest Capital Management
Puerto Rico
– -$101K -18,076 Closed
CCM
14
CAAS Capital Management
New York
– -$94K -16,771 Closed
VF
15
Virtu Financial
New York
– -$93K -16,566 Closed
FIA
16
FNY Investment Advisers
New York
– -$26.5K -4,799 -99%
UBS Group
17
UBS Group
Switzerland
– -$14K -2,566 Closed
SSB
18
Sandy Spring Bank
Maryland
– -$1K -100 Closed

VAXX Hedge Fund Activity: Q1 2022 in Review

12 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q1 2022, worth a combined $76.6M — down 25% from $102M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VAXX and 1 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Bank of America, adding an estimated $86.5K. The largest seller was Goldman Sachs, cutting an estimated $685K.

  • 12 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q1 2022, down from 17 in Q4 2021.
  • Funds reported $76.6M of Vaxxinity, Inc. Class A Common Stock stock for Q1 2022, down 25% quarter-over-quarter.
  • 1 fund opened new Vaxxinity, Inc. Class A Common Stock positions in Q1 2022 and 6 closed out, a net change of -5 holders.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q1 2022 was Bank of America, an estimated $86.5K added.
  • The largest Vaxxinity, Inc. Class A Common Stock seller in Q1 2022 was Goldman Sachs, an estimated $685K sold.

Based on aggregated 13F filings for Q1 2022.